Artiva Biotherapeutics, Inc. Common Stock — Institutional Ownership
Which tracked institutions hold ARTV, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.
13
Funds holding
$30599368
Total value held
Buying
12 added/new · 1 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Franklin Resources Inc | $19373063 | 1997223 | +1476896 | +283.84% |
| 2 | Blackrock, Inc. | $6738842 | 694726 | +481338 | +225.57% |
| 3 | Ubs Group Ag | $1784994 | 184020 | +184020 | NEW BUY |
| 4 | State Street Corp | $1607911 | 165764 | +129940 | +362.72% |
| 5 | Northern Trust Corp | $741303 | 76423 | +64215 | +526.01% |
| 6 | Goldman Sachs Group Inc | $153066 | 15780 | +4315 | +37.64% |
| 7 | Wells Fargo & Company/Mn | $53156 | 5480 | +3980 | +265.33% |
| 8 | Jpmorgan Chase & Co | $40149 | 4191 | +3968 | +1779.37% |
| 9 | Barclays Plc | $32359 | 3336 | +3336 | NEW BUY |
| 10 | Royal Bank Of Canada | $30000 | 3066 | +2878 | +1530.85% |
| 11 | Morgan Stanley | $21457 | 2212 | -14165 | -86.49% |
| 12 | Citigroup Inc | $20788 | 2143 | +2143 | NEW BUY |
| 13 | Us Bancorp \De\ | $2280 | 235 | +235 | NEW BUY |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.